1. 11β-Hydroxysteroid Dehydrogenases and Hypertension in the Metabolic Syndrome

   • Matthew A. Bailey

   Hypertension and Metabolic Syndrome (J Sperati, Section Editor) Open access 14 November 2017 Article: 100

   

2. The Role of Sympatho-Inhibition in Combination Treatment of Obesity-Related Hypertension

   • Revathy Carnagarin
   • Cynthia Gregory
   • Markus P. Schlaich

   Antihypertensive Agents: Mechanisms of Drug Action (ME Ernst, Section Editor) 28 October 2017 Article: 99

   

3. The Use of Electronic Health Records to Identify Children with Elevated Blood Pressure and Hypertension

   • Michael G. Semanik

   Pediatric Hypertension (B Falkner, Section Editor) 26 October 2017 Article: 98

4. What Is the Role of Oral Prostacyclin Pathway Medications in Pulmonary Arterial Hypertension Management?

   • Rama El Yafawi
   • Joel A. Wirth

   Pulmonary Hypertension (JR Klinger, Section Editor) 25 October 2017 Article: 97

5. Ambulatory Blood Pressure Monitoring in Children and Adolescents: a Review of Recent Literature and New Guidelines

   • Ian Macumber

   Pediatric Hypertension (B Falkner, Section Editor) 25 October 2017 Article: 96

6. The Effect of Xanthine Oxidase Inhibitors on Blood Pressure and Renal Function

   • Marilisa Bove
   • Arrigo F. G. Cicero
   • Claudio Borghi

   Antihypertensive Agents: Mechanisms of Drug Action (M Ernst, Section Editor) 25 October 2017 Article: 95

   

7. An Update on Masked Hypertension

   • D. Edmund Anstey
   • Daniel Pugliese
   • Daichi Shimbo

   Blood Pressure Monitoring and Management (J Cockcroft, Section Editor) 25 October 2017 Article: 94